Compare, Analyse Fulford India with ACTAVIS INC. - US - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

FULFORD INDIA vs ACTAVIS (US) - Comparison Results

FULFORD INDIA     Change

Fulford (India) Limited is an Indian affiliate of Schering-Plough Corporation, USA. The company has presence in oncology, virology and cardiovascular segments. In FY06 the topline of the company grew by 15.5% to Rs. 1519 m from Rs. 1279 m in FY05. PA... More

ACTAVIS (US)
   Change

Actavis, Inc. is a global, integrated specialty pharmaceutical company focused on developing, manufacturing and distributing generic, brand and biosimilar products. It develops, manufactures and market generic, branded generic, legacy brands and Over... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 FULFORD INDIA   ACTAVIS
EQUITY SHARE DATA
    FULFORD INDIA
Mar-14
ACTAVIS
Dec-18
FULFORD INDIA/
ACTAVIS
5-Yr Chart
Click to enlarge
High Rs94213,729-   
Low Rs4509,209-   
Sales per share (Unadj.) Rs691.43,367.7-  
Earnings per share (Unadj.) Rs11.5-1,084.7-  
Cash flow per share (Unadj.) Rs15.4354.9-  
Dividends per share (Unadj.) Rs2.000-  
Dividend yield (eoy) %0.30-  
Book value per share (Unadj.) Rs380.013,890.1-  
Shares outstanding (eoy) m3.90332.60-   
Bonus/Rights/Conversions ---  
Price / Sales ratio x1.03.4 29.6%   
Avg P/E ratio x60.7-10.6 -574.3%  
P/CF ratio (eoy) x45.332.3 140.2%  
Price / Book Value ratio x1.80.8 221.8%  
Dividend payout %17.40-   
Avg Mkt Cap Rs m2,7143,814,612 0.1%   
No. of employees `0000.416.9 2.6%   
Total wages/salary Rs m5050-   
Avg. sales/employee Rs Th6,073.066,277.4 9.2%   
Avg. wages/employee Rs Th1,137.40-   
Avg. net profit/employee Rs Th100.7-21,348.0 -0.5%   
INCOME DATA
Net Sales Rs m2,6961,120,088 0.2%  
Other income Rs m12521,420 0.6%   
Total revenues Rs m2,8221,141,507 0.2%   
Gross profit Rs m-4629,352 -0.2%  
Depreciation Rs m15478,813 0.0%   
Interest Rs m1064,635 0.0%   
Profit before tax Rs m54-492,677 -0.0%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0125,652 0.0%   
Tax Rs m10-6,244 -0.2%   
Profit after tax Rs m45-360,781 -0.0%  
Gross profit margin %-1.72.6 -65.7%  
Effective tax rate %17.71.3 1,395.1%   
Net profit margin %1.7-32.2 -5.1%  
BALANCE SHEET DATA
Current assets Rs m1,738459,401 0.4%   
Current liabilities Rs m545406,402 0.1%   
Net working cap to sales %44.34.7 935.5%  
Current ratio x3.21.1 282.3%  
Inventory Days Days4820 247.5%  
Debtors Days Days466 6.5%  
Net fixed assets Rs m12126,788 0.0%   
Share capital Rs m390-   
"Free" reserves Rs m1,4430-   
Net worth Rs m1,4824,619,838 0.0%   
Long term debt Rs m01,626,813 0.0%   
Total assets Rs m2,0777,221,859 0.0%  
Interest coverage x6.7-6.6 -101.4%   
Debt to equity ratio x00.4 0.0%  
Sales to assets ratio x1.30.2 837.2%   
Return on assets %2.6-4.1 -63.6%  
Return on equity %3.0-7.8 -38.6%  
Return on capital %4.3-4.8 -88.9%  
Exports to sales %00-   
Imports to sales %24.50-   
Net fx Rs m-6560-   
CASH FLOW
From Operations Rs m90400,165 0.0%  
From Investments Rs m105219,839 0.0%  
From Financial Activity Rs m-14-686,803 0.0%  
Net Cashflow Rs m181-66,466 -0.3%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ACTAVIS (US) is United States Dollars. All data has been converted at 70.95 Rs / USD

Compare FULFORD INDIA With: ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  

Compare FULFORD INDIA With: GLENMARK PHARMA  CADILA HEALTHCARE  AJANTA PHARMA  ELDER PHARMA  LUPIN  



Today's Market

Sensex Ends 95 Points Higher; Automobile and IT Stocks Witness Buying(Closing)

Indian share markets traded rangebound throughout the day and ended marginally higher. Sectoral indices ended on a mixed note with stocks in the automobile sector.

Related Views On News

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

My 3 Best Small-cap Stocks to Get Rich in this Market Rebound (Profit Hunter)

Oct 14, 2019

This is once in a decade opportunity to make a killing from smallcap rebound.

Buy these 3 Stocks for Rebound Riches

Oct 18, 2019

Equitymaster's smallcap guru and editor of Hidden Treasure, Richa Agarwal, talks to us about the rebound in the stock market, and the best stocks to profit from it. Listen in...

Two Stocks to Buy in the Great Indian Festival (Profit Hunter)

Oct 11, 2019

Discounts are not just limited to E-tailers. You can buy stocks at 50% off too. Here are two stocks to buy now.

The One Stock I Like in this Market (The 5 Minute Wrapup)

Oct 10, 2019

There are rare periods in markets when you get good quality stocks at attractive valuations. Is this one such period?

5 Smart Money Stocks to Profit from the Market Rebound (The 5 Minute Wrapup)

Oct 11, 2019

Now is the time to put money in these 5 stocks to take advantage of the recovery in the economy and the markets.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

FULFORD INDIA SHARE PRICE


Jul 30, 2015 (Close)

TRACK FULFORD INDIA

  • Track your investment in FULFORD INDIA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

FULFORD INDIA - ORCHID PHARMA LTD COMPARISON

COMPARE FULFORD INDIA WITH

MARKET STATS